Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors
<p><strong>Background:</strong><br /> Long-term antiplatelet treatment is associated with major bleeding.</p><br /> <p><strong>Aims:</strong><br /> To determine the costs associated with major bleeding in patients treated with aspirin-base...
Κύριοι συγγραφείς: | Luengo-Fernandez, R, Li, L, Rothwell, PM |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
SAGE Publications
2019
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Proton Pump Inhibitors Use in Patients With Ischemic Stroke on Dual Antiplatelet Therapy at Low Risk of Upper Gastrointestinal Bleeding
ανά: Minyoul Baik, κ.ά.
Έκδοση: (2025-01-01) -
Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
ανά: Minyoul Baik, κ.ά.
Έκδοση: (2024-06-01) -
Antiplatelet agents and proton pump inhibitors &ndash; personalizing treatment
ανά: Eugene Lin, κ.ά.
Έκδοση: (2010-06-01) -
Antiplatelet drugs and gastrointestinal disorders: when and how effective are inhibitors of proton pump?
ανά: Oksana Mikhaylovna Drapkina, κ.ά.
Έκδοση: (2011-10-01) -
Prescription Pattern of Proton Pump Inhibitors at Hospital Admission and Discharge
ανά: Verónica Gamelas, κ.ά.
Έκδοση: (2018-05-01)